Volume 19, Issue 70 (May 2009)
J Mazandaran Univ Med Sci 2009, 19(70): 9-17 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Keihanian S, Fotokian Z, Ghaffari F, Vahdani M, Shirinkam F, Saravi M. Incidence of chemotherapy-induced amenorrhea in non-menopausal women with breast cancer. J Mazandaran Univ Med Sci 2009; 19 (70) :9-17
URL: http://jmums.mazums.ac.ir/article-1-544-en.html
URL: http://jmums.mazums.ac.ir/article-1-544-en.html
Abstract: (13179 Views)
Background and purpose: Although adjunct chemotherapy may increase life in non-menopausal breast cancer patients، however، it may cause short-term complications such as nausea، vomiting، alopecia، as well as long-term complications in ovarian failure and premature menopausal. The objective of this study was to investigate chemotherapy-induced secondary amenorrhea in non-menopausal women with breast cancer.
Materials and methods: A descriptive design (case series) was preformed on fifty breast cancer patients، non-menopausal (normal mense) and chemotherapy in Ramsar Emam Sajad Hospital Oncology unit from 2007 to 2008. Sampling was consecutive. Data gathering method was questionnaire & blood sampling (FSH & Progesterone) for prior and 12 months after the end of chemotherapy. Data was analyzed by paired-t، independent-t and one-way ANOVA tests.
Results: Results showed that 62% of patients were amenorrhea 12 months after the end of chemotherapy. Results showed that there was no meaningful relationship between age، hormone therapy، disease stage، node-positive and ER & PR status to amenorrhea however، there was a meaningful relationship between duration of treatment، type and dose of chemotherapy to amenorrhea.
Conclusion: In pre-menopausal patients with breast cancer، receiving cytotoxic chemotherapy against tumor cells، amenorrhea may occur do to ovarian failure.
Materials and methods: A descriptive design (case series) was preformed on fifty breast cancer patients، non-menopausal (normal mense) and chemotherapy in Ramsar Emam Sajad Hospital Oncology unit from 2007 to 2008. Sampling was consecutive. Data gathering method was questionnaire & blood sampling (FSH & Progesterone) for prior and 12 months after the end of chemotherapy. Data was analyzed by paired-t، independent-t and one-way ANOVA tests.
Results: Results showed that 62% of patients were amenorrhea 12 months after the end of chemotherapy. Results showed that there was no meaningful relationship between age، hormone therapy، disease stage، node-positive and ER & PR status to amenorrhea however، there was a meaningful relationship between duration of treatment، type and dose of chemotherapy to amenorrhea.
Conclusion: In pre-menopausal patients with breast cancer، receiving cytotoxic chemotherapy against tumor cells، amenorrhea may occur do to ovarian failure.
Type of Study: Research(Original) |
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s). Owned by Mazandaran University of Medical Sciences.
Contact Us
Address: Journal Office, Building No. 2, Mazandaran University of Medical Sciences, Moallem Square, Sari.Tel: +98 (011)34484874 Postal code: 48175-866 E-Mail: jmums@mazums.ac.ir Telefax: +98 (011)33262679
